31/05/2024  21:59:57 Var. +0.78 Volume Denaro- Lettera- Capitalizzazione di mercato Dividend Y. Rapporto P/E
82.04USD +0.96% 38,169
Fatturato: 3.11 mill.
-Quantità in denaro: - -Quantità in lettera: - 19.23 bill.USD 3.17% 31.80

Descrizione business

The Principal Financial Group® (The Principal®)1 is a global investment management leader offering retirement services, insurance solutions and asset management. The Principal offers businesses, individuals and institutional clients a wide range of financial products and services, including retirement, asset management and insurance through its diverse family of financial services companies.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Daniel J. Houston
Consiglio di amministrazione
Deanna D. Strable, Amy C. Friedrich, Patrick G. Halter, Christopher J. Littlefield, Thomas Cheong, Jon N. Couture, Kathleen B. Kay, Natalie Lamarque, Bethany A. Wood, Kamal Bhatia, Noreen M. Fierro, Teresa Hassara, Kara M. Hoogensen, Kenneth A. McCullum, Dennis J. Menken, Joel M. Pitz, Srinivas D. (Sri) Reddy, Nate Schelhaas, Anthony Shea Treadway, Ellen W. Shumway, Vivek Agrawal, J. Scott Boyd, Timothy A. Hill, Christopher D. Payne
Consiglio di sorveglianza
Daniel J. Houston, Alfredo Rivera, Blair C. Pickerell, Clare S. Richer, Claudio N. Muruzabal, Diane C. Nordin, H. Elizabeth Mitchell, Jocelyn Carter-Miller, Jonathan S. Auerbach, Mary E. Beams, Roger C. Hochschild, Scott M. Mills
 

Dati aziendali

Name: Principal Financial Group Inc.
Indirizzo: 711 High Street,Des Moines, IA 50392, USA
Telefono: +1-515-247-5111
Fax: -
E-mail: -
Internet: www.principal.com
Industria: Financial
Settore: Insurance
Sub settore: -
Fine dell'anno finanziario: 31/12
Flottante libero: 62.90%
Data dell'IPO: 23/10/2001

Rapporti con gli investitori

Name: Humphrey Lee
IR telefono: +1-515-235-9500
IR Fax: -
IR e-mail: investor-relations@p...pal.com investor-relations@principal.com

Company calendar

CW 23 | 03/06/2024 Ex-Dividend
CW 23 | 04/06/2024 Record Date
CW 26 | 27/06/2024 Dividend Payment
CW 30 | 26/07/2024 Interim Report 2nd Quarter/6 Months
CW 43 | 25/10/2024 Interim Report 3rd Quarter/9 Months